[ Price : $8.95]
FDA accepts for priority review a Genentech sBLA for a new indication for its Tecentriq.[ Price : $8.95]
Attorney Anne Walsh outlines Justice Department changes to the Yates memo on individual accountability in criminal and civil cases...[ Price : $8.95]
The Federal Trade Commission says it shares FDA concerns about abuse of the citizen petition process to delay approval of generic ...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that include Barox Co., Globus Medical and MiBo Medical Group.[ Price : $8.95]
FDA issues a proposed rule to change the submission and review requirements for the medical device de novo classification pathway.[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Aspire Bariatrics medical d...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Synergy Pharmaceuticals Tru...[ Price : $8.95]
FDA determines for patent extension purposes the regulatory review period for Intercept Pharmaceuticals Ocaliva (obeticholic acid)...